Is MSH2 a breast cancer susceptibility gene?

Familial Cancer

Volumn 7, Issue 2, 2008, Pages 151-155

  Wong, Ee Ming ^a   Tesoriero, Andrea A ^a   Pupo, Gulietta M ^b   McCredie, Margaret R E ^c   Giles, Graham G ^d   Hopper, John L ^a   Mann, Graham J ^b   Goldgar, David E ^e   Southey, Melissa C ^a,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Breast cancer susceptibility genes; Candidate susceptibility genes; Familial breast cancer; Linkage studies; MSH2

Indexed keywords

PROTEIN MSH2;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 2P; COLORECTAL CANCER; EXON; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MISMATCH REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 45749114567     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9162-8     Document Type: Article

References (23)

1. Smith P, McGuffog L, Easton DF et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45:646-655
2. Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677-85
3. Aarno M, Mcklin JP, Aaltonen LA et al (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433
4. Risinger JI, Barrett JC, Watson P et al (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumour in patients with the hereditary non-polyposis colorectal carcinoma syndrome. Cancer 77:1836-1843
5. Southey MC, Young MA, Whitty J et al (2001) Molecular Pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis. Am J Surg Path 25:936-941
6. Muller A, Edmonston TB, Corao DA et al (2002) Exclusion of breast cancer as an integral tumour of hereditary nonpolyposi colorectal cancer. Cancer Res 62:1012-1019
7. de Leeuw WJ, Puijenbroek M, Tollenaar RAEM et al (2003) Correspondence re Muller et al. exclusion of breast cancer as an integral tumour of hereditary nonpolyposi colorectal cancer. Cancer Res 63:1148-1149
8. Scott RJ, McPhillips M, Meldrum CJ et al (2001) Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68:118-127
9. Vasen HFA, Morreau H, Nortier JWR (2001) Is breast cancer part of the tumour spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68:1533-1534
10. http://www.kconfab.org. Accessed Sept 2007
11. Hopper JL, Chenevix-Trench G, Jolley DJ et al (1999) Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 26:95-100
12. Hopper JL, Giles GG, McCredie MR, Boyle P (1994) Background rational and protocol for a case-control-family study of breast cancer. Breast 3:79-86
13. McCredie MR, Dite GS, Giles GG, Hopper JL (1998) Breast cancer in Australian women under the age of 40. Cancer Causes Control 9:189-198
14. Dite GS, Jenkins MA, Hocking JS et al (2002) Strong familial risks associated with early-onset breast cancer are only partially BRCA1- or BRCA2-related. JNCI 19:95,448-457, 2003
15. Chenevix-Trench G, Spurdle AB, Gatei M et al (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94, 205-215. Erratum in: J Natl Cancer Inst 2002 94, 952
16. Smith LD, Tesoriero AA, Ramus SJ et al (2007) BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study. Eur J Cancer 43:823-827
17. Mann GJ, Thorne H, Belleine RL et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12. Epub 2006 Feb 13
18. Southey MC, Jenkins MA, Mead L et al (2005) Mismatch repair gene mutation testing, immunohistochemistry and microsatellite instability testing in a population-based series of unselected early-onset colorectal cancers. J Clin Oncol 23:6524-6532
19. Smith L, Tesoriero A, Mead L et al (2006) Genomic rearrangements in hMSH2 and hMLH1 in early-onset colorectal cancer: a population-based study. Clin Genet 70:250-252
20. Tesoriero AA, Wong EM, Jenkins MA et al (2005) Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat 26:495
21. http://www.violin.genet.sickkids.on.ca/~ali/splicesitefinder.html. Accessed Sept 2006
22. Wehner M, Buschhausen L, Lamberti C et al (1997) Hereditary nonpolyposis colorectal cancer (HNPCC): eight novel germline mutations in hMSH2 or hMLH1 genes. Hum Mutat 10:241-244
23. Wijnen J, Vasen H, Khan PM et al (1995) Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56:1060-1066